Figure 1.
Survival from the time of first ibrutinib initiation. (A) OS, (B) PFS, (C) OS stratified by 2L vs later-line ibrutinib use, and (D) PFS stratified by 2L vs later-line ibrutinib use.
Survival from the time of first ibrutinib initiation. (A) OS, (B) PFS, (C) OS stratified by 2L vs later-line ibrutinib use, and (D) PFS stratified by 2L vs later-line ibrutinib use.
